CXCL12 is a chemokine known to regulate migration, proliferation, and differentiation of neural stem cells (NSCs) and to play a neuroprotective role in ischemic stroke. Chitosan-dextran sulfate nanocomplexes (Ch/DS NC) are known nanoparticulated systems used to efficiently deliver heparin-binding factors. Here we evaluate Ch/DS NC as carriers for CXCL12 in a mouse model of stroke. Free CXCL12 reduced the size of the ischemic brain lesion. However, when Ch/DS NC were administrated, the stroke volume increased. Neurotoxic screening revealed that Ch/DS NC reduced neuronal viability, decreased the extension of neurites and impaired NSC migration in vitro. To the best of our knowledge, neurotoxicity of Ch/DS NC has not been reported and further screenings will be needed in order to evaluate the biological safety of these nanocomposites. Our results add new data on nanoparticle neurotoxicity and may help us to better understand the complex interactions of the nanostructures with biological components.
Introduction
C-X-C chemokine ligand 12 (CXCL12), also known as stromal-derived factor-1 (SDF-1), is a chemokine that regulates migration, proliferation, and differentiation of neural stem cells (NSCs) within the developing central nervous system (CNS) (Li, Tang et al. 2015) . Although there is some controversy (Pan, Yan et al. 2016 , Cheng, Lian et al. 2017 , Wu, Yu et al. 2017 , there is increasing evidence showing that CXCL12 overexpression or delivery improves neurobehavioral recovery during post-ischemic stroke (Shyu, Lin et al. 2008 , Li, Tang et al. 2015 . Previous treatment of stroke with CXCL12 was shown to upregulate CXCL12/CXCR4 axis and enhance neurogenesis, angiogenesis, and neurological outcome (Shyu, Lin et al. 2008 , Yoo, Seo et al. 2012 , Kim, Seo et al. 2015 . However, CXCL12 is prone to inactivation, denaturation, and degradation and improving its in vitro stability and in vivo half-life is essential for clinical applications (Zaman, Wang et al. 2016 ).
The CXCL12 protein structure has a heparin-binding site, which allows it to bind to heparan sulfate, form dimers that are less susceptible to protease inactivation, and interact with target cells via cell surface receptors. Since dextran sulfate (DS) has similar structural properties as heparin and heparan sulfate, it can bind CXCL12 in a way similar to that of its natural polymeric ligands. DS is a polyanion that can form polyelectrolyte complexes through electrostatic interactions with the polycation Chitosan (Ch) (Bader, Li et al. 2015) .
Chitosan-dextran sulfate nanocomplexes (Ch/DS NC) have advantages for protein delivery compared to other nanoparticle systems, such as high hydrophilicity. Complexes are produced in water via charge-charge interactions, which pose minimal risk for denaturation or inactivation of the incorporated proteins. Additionally, binding to DS or Ch in the matrix of nanocomplexes provides dynamic immobilization and protection of the incorporated proteins (Bader, Li et al. 2015 , Zaman, Wang et al. 2016 ).
In fact, CXCL12 associated with Ch/DS NC exhibit enhanced stability and sustained in vivo effects/retention (Zaman, Wang et al. 2016) . When aerosolized into the lungs of rats, CXCL12 Ch/DS NC exhibited longer retention time than that of free CXCL12 (t 1/2 = 20 h, and 3.2 h, respectively; 29% remaining after 72 h and 2% after 16 h, respectively). The aerosolized CXCL12 Ch/DS NC, but not free CXCL12, reduced pulmonary artery pressure in rats (Yin, Bader et al. 2013 ).
As far as we know CXCL12 Ch/DS NC have not been used in brain injuries and Ch/DS NC neurotoxicity has not been tested. In this work we evaluated Ch/DS NC as a carrier for CXCL12 in a stroke mouse model. However, we found evidence that Ch/DS NC increased stroke area, worsened mice motor deficits after ischemia, and decreased cell viability and neurite length in vitro.
Materials and Methods

Cells
Jurkat cells (human acute T lymphocytic leukemia cell line) were cultured in RPMI1640 medium (Cultilab,Campinas, Brazil) with 10% fetal bovine serum (FBS, Cultilab), 1% glutamine (Gibco, Waltham, USA), and 1% penicillin/streptomycin antibiotics (Gibco).
N2a cells (murine neuroblastoma cell line) were cultured in high glucose DMEM medium (Gibco) with 10% FBS, 1% glutamine and 1% penicillin / streptomycin.
Adult neural stem cells (NSCs) were obtained from the subventricular zone (SVZ) of 45 days old C57BL/6 female mice according to previous described protocol (Adelita, Stilhano et al. 2017) . Cells were cultured in DMEM/F 12 1:1 (v/v) (Gibco), supplemented with 2% B27 (Thermo Fischer, Waltham, USA), 20 ng/mL EGF (Sigma, St Louis, USA), 20 ng/mL FGF2 (Sigma), 1% penicillin/streptomycin (Gibco), and 5 μ g/mL heparin. Cells were plated on a poly 2-hydroxyethyl metracrylate (poly HEMA) (Sigma) pre-coated 75 cm 2 flask to avoid adhesion. Neurospheres formation takes up to 14 days to occur, and during this time culture medium was partially changed every 3 days.
All cells were kept at 37°C and 5% CO 2 .
Nanocomplexes (NC)
Production of CXCL12 Ch/DS NC CXCL12 Ch/DS NC were produced following a protocol described (des Rieux, Ucakar et al. 2011) . Five µl of CXCL12 (1 µg/µL) (Peprotech, Rocky Hill, USA)
were added to 50 µL of 1% DS (500 kDa, Fluka, Buchs, Switzerland) and stirred for 30 min. One hundred µL of 0.1% chitosan solution (Polysciences, Valley
Road, Warrington) prepared in 1% acetic acid (pH 5) were added dropwise to the CXCL12-DS solution and stirred for 5 min. 
CXCL12 release
Five µL NC were suspended in 200 µl of PBS (n=3). Samples were incubated at 37 ºC and at given times, were centrifuged at 14000 g for 30 min at room temperature. Supernatants were collected and frozen until further analysis.
CXCL12 was quantified from the supernatants using Mouse CXCL12 DuoSet ELISA (R&D Systems).
Western Blot
Purified CXCL12 and CXCL12 Ch/DS NC were resolved by 15% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (Bio-Rad, Hercules, USA) and electro transferred to a polyvinylidene difluoride (PVDF) membrane (Merck Millipore, Burlington, EUA). After blocking with 5% bovine serum albumin (BSA; Sigma), the PVDF membrane was sequentially probed with specific primary antibodies (1:1000, anti-CXCL12, rabbit Ig G, Abcam, Cambridge, UK) and HRP-conjugated secondary antibodies (1:5000, Santa
Cruz, Dallas, USA.). The blots were then visualized using the SuperSignal TM West Pico (Thermo Fischer) enhanced chemiluminescence detection system and recorded using a Gel Documentation 2000 system (Bio-Rad).
CXCL12 Bioactivity
In vitro CXCL12 bioactivity after its encapsulation in Ch/DS NC was evaluated by Jurkat migration assay (Zamproni, Mundim et al. 2017) .CXCL12 Ch/DS NC were added to 700 µL of migration buffer (RPMI supplemented with 0.5% bovine fetal serum) and were placed in 24 well plate. A Transwell cell insert (8 µm pore, Corning, New York, USA) was placed in each well containing the NC.
Then, 4x10 5 Jurkat cells (100 µL) were added in the apical chamber of the inserts. Migration buffer alone was used as negative control and a CXCL12 standard curve (50 ng/mL to 200 ng/mL) was used as a positive control. Cells were incubated at 37°C for 4 h in a 5% CO 2 incubator. Transwell inserts were then removed and the number of cells that migrated in the lower chamber were measured by counting them with a Neubauer chamber.
NC internalization
Fluorescent Ch/DS NC were produced using a conjugated FITC-dextran-sulfate (500 kDa, Sigma). Four thousand N2a cells were seeded in the bottom of a 24-well plate and allowed to adhere overnight. Cells were then incubated with Ch/DS NC for 1, 3 or 24 hours and fixed with 4% paraformaldehyde. Nuclei were stained with DAPI (4′,6-diamidino-2-phenylindole ,1:500, Molecular
Probes, Eugene, USA) and images were obtained using a scanning confocal inverted microscope (TCS, SP8 Confocal Microscope, Leica, Wetzlar, Germany). Fluorescence was calculated by dividing FITC integrated density by DAPI integrated density.
Effects of CXCL12 Ch/DS NC on normal brain cortex
Seven-week C57BL/6 female mice were submitted to surgery under anesthesia with intraperitoneal administration of acepromazine (1 mg/Kg, Vetnil, Louveira, 
Protein extraction
Frozen cortexes were homogenized in radioimmunoprecipitation assay (RIPA)
buffer containing a protein inhibitor cocktail (Sigma). Samples were centrifuged at 7000 g for 5 min at 4°C. Supernatants were collected and frozen at -80 °C until further analysis. The protein amount in each sample was determined by Bio Rad DC Protein Assay (Bio Rad).
ELISA (Enzyme-Linked Immunosorbent Assay)
The amount of CXCL12, interleukin 6 (IL-6), interleukin 10 (IL-10) and tumor necrosis factor α (TNF-α) in protein homogenates from brain cortexes was measured by sandwich ELISA following the instructions of each detection Kit. 
Stroke model
Cortical photothrombosis was induced by the Rose Bengal technique (Labatgest and Tomasi 2013). Seven-week C57BL/6 female mice were submitted to surgery as described above. Anaesthetized mice were placed in a stereotaxic frame and the scalp incised, Rose Bengal (10mg/Kg, 15 mg/ml solution in sterile PBS) was injected intraperitoneally and the skull was illuminated for 20 min.
Immediately after the procedure, intracerebroventricular injection of 5 µL of PBS, NC Ch/DS, CXCL12 20 ng/mL or NC Ch/DS/CXCL12 20 ng/mL was performed as previously described. The scalp was sutured and the mice left to recover in a 30°C chamber for 1 h prior to returning to their home cage.
Mice were provided a dish of moist food in their home cage for the duration of their post-stroke survival. Mice were weighted every day. Brains were collected 3 days later. Mice were anesthetized and euthanized by cervical dislocation.
Next, the brains were removed, stained with 2% 2,3,5-Triphenyl-tetrazolium (TCC, Alphatec, São José dos Pinhais, Brazil) at room temperature for 20 min and immersed in 4% paraformaldehyde for 24 h. To estimate the amount of cerebral tissue lost after stroke, the brains were sectioned into 2 mm coronal slices using a manual sectioning block, and the lost tissue area in each slice was determined by subtracting the area of the injured hemisphere from the area of the normal hemisphere using Image J software. The volume of brain tissue lost was determined by the sum of each slice area multiplied by the thickness 
Behavioral assessment: Grid walking
To verify limb sensitivity, mice were recorded while walking over a grid for 4 min. The brain injury was in the left cortex, so as the mouse walked over the grid, its right paws falls, because it could not grasp the grid properly. The number of falls reflects the severity of the lesion (López-Valdés, Clarkson et al.
2014).
Ch/DS NC neurotoxicity
MTT ( 
Measurement of ROS Production
Reactive oxidative species (ROS) production was measured by using 2',7' -dichlorofluorescin diacetate (DCFDA, Sigma). DCFDA is cell-permeable and, 
Neurosphere migration
Neurospheres were plated in laminin coated coverslips, incubated with different Ch/DS NC concentrations (from 5 µL/mL to 100 µL/mL) for 24 h and were photographed using an inverted microscope (Olympus, Tokyo, Japan). The distance from the edge of the sphere to the farthest migrated cells was measured at four distinct locations per sphere using ImageJ and the average of this value was calculated (Kong, Fan et al. 2008) .
Statistical analysis
Statistically significant differences were evaluated by one-way ANOVA followed
by Tukey post-test using GraphPad Prism software version 5.01 (GraphPad Software, USA). Results are expressed as mean ± standard error of mean and were considered significant if p<0.05. The presence of the symbol * represents that data is different from control.
Results
Characterization of CXCL12 Ch/DS NC
Ch/DS NC and CXCL12 Ch/DS NC had a mean size of 186 and 143 nm, respectively (Table 2) . Their zeta potential was in average -25 mV and EE was 75% while CXCL12 loading was 19 ng per stock µL formulation.
Based on CXCL12 loading, 2.5 µL and 5 µL of CXCL12 Ch/DS NC stock solution containing 50 ng and 100 ng of CXCL12, respectively, were used for the following experiments.
We found minimal CXCL12 release from CXCL12 Ch/DS NC in vitro, with only 0.5% of the total amount of protein released after 7 days (Figure 2A ), although we confirmed the presence of CXCL12 in the pellet by Western blot ( Figure 2B ).
CXCL12 bioactivity was preserved in the complexes and calculated as 80,4% ± 9,1% of free CXCL12 (n=3) ( Figure 2C ).
N2a cells were able to internalize NC. Internalization was shown to increase with time, but not with increasing NC concentration in media (Figures 2D and E) .
CXCL12 Ch/DS NC were capable of increase CXCL12 receptors in vivo
First, we assessed whether CXCL12 Ch/DS NC were able to increase the concentration of CXCL12 in the cerebral cortex or its receptors after intracerebroventricular injection. CXCL12 protein levels were quantified in the cortex ipsilateral to the injection. No increased CXCL12 concentration was detected in any of the groups who received free CXCL12 or CXCL12 Ch/DS NC at day 1 and 3 ( Figure 3A) . Similarly, no increased of Cxcl12 gene expression was observed in any of the groups ( Figure 3B ). However, the gene expression of Cxcr7, a CXCL12 receptor, significantly increased 1 day after injection of CXCL12 Ch/DS NC compared to PBS ( Figure 3C ). Cxcr4 gene expression, another receptor for CXCL12, significantly increased 3 days after injection of CXCL12 Ch/DS NC compared to PBS ( Figure 3D ).
Ch/DS NC are deleterious in stroke
After characterization, we attempted to verify the CXCL12 Ch/DS NC therapeutic ability in a photothrombotic mice stroke model. Surprisingly, animals who received empty Ch/DS NC presented increased infarct area ( Figures 4A and B) associated with worse performance in the grid test ( Figure 4C ). To confirm these data the experiment was repeated using a different model of stroke, the permanent distal occlusion of the left middle cerebral artery. Again, a significant increase in ischemic injury was observed in animals receiving Ch/DS NC ( Figure 5 ).
Ch/DS NC decreases cell viability
The increase in the ischemic area in animals that received the Ch/DS NC brought us the concern about their safety. So, we conducted assays to verify the compatibility of NC with brain tissue.
First, cell viability was verified by MTT assay, using two cellular types, a murine neuroblastoma cell lineage (N2a) and a primary culture of neural stem cells (NSCs) extracted from SVZ, for 24 h. We observed that in both N2a and NSCs viability was slightly decreased after exposure to Ch/DS NC for 24 h ( Figures   6A and B) . Viability was maintained when CXCL12 was added to the formulation ( Figure 6C ). Since oxidative stress is one of the causes of death in cells exposed to nanoparticles (Khanna, Ong et al. 2015) , we verified whether NC could increase ROS production using DCFDA. We found that neither Ch/DS NC or CXCL12 Ch/DS NC increased ROS production in 4 or 24 h ( Figure 6D and E).
However, during the experiments we realized that when trying to incubate the cells with NC for longer periods, at the end of 72 hours there were practically no more cells in the wells. To confirm this, we repeated the MTT assay, this time exposing the cells to the NCs for 4 or 24 hours. After this period the NC containing medium was removed, the cells washed and incubated with normal culture medium ( Figure 7A ). At 72 hours, the MTT assay confirmed there were no more viable cells in the wells ( Figure 7B and C). Two possibilities occurred to us to explain this result: either the cells died from exposure or were stopping to divide. For this reason, we decided to check for a possible interaction of NCs with cytoskeleton.
Ch/DS NC decreases neurite length
To evaluate the interaction of NCs with cytoskeleton, we evaluated the morphology of neural cells and NSC ability to migrate. Neurite length in N2a
and NSCs was dramatically decreased by Ch/DS NC ( Figure 8A ). Also, Ch/DS NC impaired neuroblasts emigration from neurospheres ( Figure 8A ). When CXCL12 was added to the formulation, neurite outgrowth impairment was not significant, but their size remained 50 to 80 µm shorter ( Figure 8B ).
CXCL12 Ch/DS NC upregulates the production of anti-inflammatory interleukins in brain cortex
To detect a potential effect of CXCL12 Ch/DS NC on inflammation, IL-10, IL-6
and TNF-α concentrations in the ipsilateral normal cortex to the injection were quantified. Twenty-four hours after CXCL12 Ch/DS NC injection IL-6 concentration was increased in brain tissue when compared to PBS ( Figure   9A ). IL-10 production increased in animals treated with CXCL12 Ch/DS NC after 72 h ( Figure 9B ). No impact on TNF-α concentrations was observed disregard of treatments ( Figure 9C ).
Discussion
In this study, we found evidence that Ch/DS NC exert deleterious effects on brain tissue when administered intracerebroventricularly in mice. Indeed, the experimental group that received Ch/DS NC showed increased stroke volume and presented worsened performance in the grid walking test. Also, a decrease in N2a and NSCs viability and neurite length in vitro was observed.
The Ch/DS NC used in this work are not new and have already been described previously (des Rieux, Ucakar et al. 2011 , Yin, Bader et al. 2013 , Bader, Li et al. 2015 . The characterization conducted in this work show NC with characteristics very similar to those previously described (Bader, Li et al. 2015) .
Reports have shown that engineered nanomaterials can enter the brain and Nanoparticles can exert deleterious effects by acting in several pathways. The primary mechanism of nanoparticle toxicity involves the production of ROS and free radicals leading to oxidative stress reactions and inflammation (Yuan, Hu et al. 2015 , Teleanu, Chircov et al. 2018 . In this study, we found no evidence for increased oxidative stress reactions.
Many studies have indicated that nanomaterial exposure induces cytoskeleton disruption and cell-morphology changes (Xu, Piett et al. 2013 , Kang, Liu et al. 2016 , Liu, Kang et al. 2017 . In this study, we observed a change in CXCL12 could be delivered in its free form. Our data showed that free CXCL12 was able to reduce ischemic injury. However as previously attested, the chemokine in its free form is unstable and prone to inactivation. In this case, other formulations capable of encapsulating CXCL12 could be useful for chemokine delivery (Zamproni, Mundim et al. 2017 ).
Although not yet used in stroke therapy, nanoparticulate systems and in particular chitosan-based nanoparticles have been extensively studied as promising for treatment in a number of conditions. Unfortunately, few articles seek to investigate possible deleterious consequences of these complexes. The authors would like to draw attention to the need for a better understanding of the neurotoxicity of these compounds and the need to design new neuroprotective therapies.
Conclusions
Here we evaluated Ch/DS NC as a possible carrier for CXCL12 in a mouse model of stroke. However, the complexes turned out to be neurotoxic. Our results add new data on nanoparticle neurotoxicity and may help to better understand the complex interactions of the nanostructures with biological components and to design new neuroprotective therapies.
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